Heinz Freisling

researcher

Heinz Freisling is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0001-8648-4998

P735given nameHeinzQ11682369
HeinzQ11682369
P106occupationresearcherQ1650915

Reverse relations

author (P50)
Q40364501A metabolomic study of biomarkers of meat and fish intake
Q57417055A prospective evaluation of plasma polyphenol levels and colon cancer risk
Q35474078A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk
Q57025547A treelet transform analysis to relate nutrient patterns to the risk of hormonal receptor-defined breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Q36472414Acrylamide and glycidamide hemoglobin adduct levels and endometrial cancer risk: A nested case-control study in nonsmoking postmenopausal women from the EPIC cohort
Q44279727Adherence to the World Cancer Research Fund/American Institute for Cancer Research guidelines and risk of death in Europe: results from the European Prospective Investigation into Nutrition and Cancer cohort study1,4.
Q63865705Adherence to the mediterranean diet and lymphoma risk in the european prospective investigation into cancer and nutrition
Q92760405Adult Overweight and Survival from Breast and Colorectal Cancer in Swedish Women
Q55015227Alcohol intake in relation to non-fatal and fatal coronary heart disease and stroke: EPIC-CVD case-cohort study.
Q51143339Anthropometric measures and bladder cancer risk: a prospective study in the EPIC cohort.
Q93085607Antibody Responses to Fusobacterium nucleatum Proteins in Prediagnostic Blood Samples are not Associated with Risk of Developing Colorectal Cancer
Q78878614Association Between Soft Drink Consumption and Mortality in 10 European Countries
Q63865706Association between physical activity and risk of hepatobiliary cancers: A multinational cohort study
Q63681926Association of Selenoprotein and Selenium Pathway Genotypes with Risk of Colorectal Cancer and Interaction with Selenium Status.
Q91990595Blood pressure and risk of cancer in the European Prospective Investigation into Cancer and Nutrition
Q41620807Body iron status and gastric cancer risk in the EURGAST study
Q91759057Cancers in France in 2015 attributable to insufficient physical activity
Q43441117Challenges in estimating the validity of dietary acrylamide measurements
Q47623091Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations
Q55515012Coffee and Tea Consumption and the Contribution of Their Added Ingredients to Total Energy and Nutrient Intakes in 10 European Countries: Benchmark Data from the Late 1990s.
Q59511470Coffee and tea consumption and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition
Q46004843Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-results from the EPIC cohort study.
Q37043254Comparison of abdominal adiposity and overall obesity in relation to risk of small intestinal cancer in a European Prospective Cohort
Q53400122Comparison of standardised dietary folate intake across ten countries participating in the European Prospective Investigation into Cancer and Nutrition.
Q64108678Consumption of nuts and seeds and pancreatic ductal adenocarcinoma risk in the European Prospective Investigation into cancer and Nutrition
Q91390540Cumulative exposure to premenopausal obesity and risk of postmenopausal cancer: A population-based study in Icelandic women
Q63865854Dairy Product Intake and Risk of Type 2 Diabetes in EPIC-InterAct: A Mendelian Randomization Study
Q36074892Diet Quality Scores and Prediction of All-Cause, Cardiovascular and Cancer Mortality in a Pan-European Cohort Study
Q96811693Diet and sedentary behaviour in relation to mortality in US adults with a cardiovascular condition. Results from the National Health and Nutrition Examination Survey linked to the US mortality registry
Q57271316Dietary acrylamide intake of adults in the European Prospective Investigation into Cancer and Nutrition differs greatly according to geographical region
Q40926722Dietary and lifestyle determinants of acrylamide and glycidamide hemoglobin adducts in non-smoking postmenopausal women from the EPIC cohort
Q41664327Dietary fat, fat subtypes and hepatocellular carcinoma in a large European cohort
Q39071920Dietary flavonoid intake and colorectal cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort.
Q34973549Dietary intake of acrylamide and epithelial ovarian cancer risk in the european prospective investigation into cancer and nutrition (EPIC) cohort
Q57026302Dietary intake of acrylamide and esophageal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort
Q91180253Dietary intake of advanced glycation end products (AGEs) and changes in body weight in European adults
Q60472166Dietary intake of total polyphenol and polyphenol classes and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
Q51545063Dietary reporting errors on 24 h recalls and dietary questionnaires are associated with BMI across six European countries as evaluated with recovery biomarkers for protein and potassium intake.
Q92513754Estimated Substitution of Tea or Coffee for Sugar-Sweetened Beverages Was Associated with Lower Type 2 Diabetes Incidence in Case-Cohort Analysis across 8 European Countries in the EPIC-InterAct Study
Q112776855Food biodiversity and total and cause-specific mortality in 9 European countries: An analysis of a prospective cohort study
Q44737409Fruit and vegetable consumption and prospective weight change in participants of the European Prospective Investigation into Cancer and Nutrition-Physical Activity, Nutrition, Alcohol, Cessation of Smoking, Eating Out of Home, and Obesity study
Q33845683Fruit and vegetable intake and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Q90753430Gallstones and incident colorectal cancer in a large pan-European cohort study
Q63865892General and abdominal adiposity and the risk of Parkinson's disease: A prospective cohort study
Q41566014General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition
Q92435433Generalizability of a Diabetes-Associated Country-Specific Exploratory Dietary Pattern Is Feasible Across European Populations
Q100463647Gilbert's syndrome, circulating bilirubin and lung cancer: a genetic advantage?
Q57987944Haem iron intake and risk of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
Q90348979Healthy lifestyle and the risk of pancreatic cancer in the EPIC study
Q43745661Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European Prospective Investigation into Nutrition and Cancer Study
Q92523734Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study
Q34882075Lifestyle, dietary factors, and antibody levels to oral bacteria in cancer-free participants of a European cohort study
Q34614320Macronutrient composition of the diet and prospective weight change in participants of the EPIC-PANACEA study
Q39266106Main nutrient patterns and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition study
Q41456322Main nutrient patterns are associated with prospective weight change in adults from 10 European countries
Q40341987Measured Adiposity in Relation to Head and Neck Cancer Risk in the European Prospective Investigation into Cancer and Nutrition
Q40475158Meat and haem iron intake in relation to glioma in the European Prospective Investigation into Cancer and Nutrition study.
Q113757779Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Q58545759New cancer cases attributable to diet among adults aged 30-84 years in France in 2015
Q40112641Nut intake and 5-year changes in body weight and obesity risk in adults: results from the EPIC-PANACEA study
Q92605479Nutrient-wide association study of 92 foods and nutrients and breast cancer risk
Q40701898Overweight duration in older adults and cancer risk: a study of cohorts in Europe and the United States
Q51327120Plasma alkylresorcinol concentrations, biomarkers of whole-grain wheat and rye intake, in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
Q37532623Plasma alkylresorcinols, biomarkers of whole-grain wheat and rye intake, and incidence of colorectal cancer
Q35078928Plasma elaidic acid level as biomarker of industrial trans fatty acids and risk of weight change: report from the EPIC study
Q52870397Plasma fetuin-A concentration, genetic variation in the AHSG gene and risk of colorectal cancer.
Q44672526Polymorphisms of Helicobacter pylori signaling pathway genes and gastric cancer risk in the European Prospective Investigation into Cancer-Eurgast cohort
Q38748363Pre-diagnostic copper and zinc biomarkers and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort
Q39755745Pre-diagnostic meat and fibre intakes in relation to colorectal cancer survival in the European Prospective Investigation into Cancer and Nutrition
Q90943329Predicted basal metabolic rate and cancer risk in the European Prospective Investigation into Cancer and Nutrition
Q50724138Prospective association of liver function biomarkers with development of hepatobiliary cancers.
Q47552552Prospective evaluation of antibody response to Streptococcus gallolyticus and risk of colorectal cancer
Q39871824Region-specific nutrient intake patterns exhibit a geographical gradient within and between European countries
Q50094285Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis
Q40813284Serum Endotoxins and Flagellin and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort
Q100749853Soluble Receptor for Advanced Glycation End-products (sRAGE) and colorectal cancer risk: a case-control study nested within a European prospective cohort
Q40627556Sweet-beverage consumption and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Q33901167Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study
Q43704746Tea and coffee consumption and risk of esophageal cancer: the European prospective investigation into cancer and nutrition study
Q41318116The Association between Glyceraldehyde-Derived Advanced Glycation End-Products and Colorectal Cancer Risk
Q100312831The Association between Serum Bilirubin Levels and Colorectal Cancer Risk: Results from the Prospective Cooperative Health Research in the Region of Augsburg (KORA) Study in Germany
Q34733641The association between dietary energy density and type 2 diabetes in Europe: results from the EPIC-InterAct Study
Q57454968Timing of eating across ten European countries - results from the European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study
Q57026176Total, caffeinated and decaffeinated coffee and tea intake and gastric cancer risk: Results from the EPIC cohort study
Q92752846Vitamin D-Related Genes, Blood Vitamin D Levels and Colorectal Cancer Risk in Western European Populations

Search more.